Esophageal cancer, which is cancer of the swallowing tube, has only a 22.2% five-year relative survival rate, but early ...

Urological tumors, including prostate cancer and urothelial carcinomas, remain major contributors to global cancer morbidity and mortality. Despite recent ...

Nadine and David Lipworth have devoted their lives to finding treatment that will restore the daughter they knew.

As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...

A study recently published in Current Molecular Pharmacology has uncovered a novel mechanism by which the long non‑coding RNA ...

Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

According to MarketsandMarkets™, the Epigenetics Market is projected to grow from about USD 2.22 billion in 2026 to USD 3.92 ...

Resalis Therapeutics today announced the dosing of the first participant in a Phase 1b clinical study of its lead candidate, RES-010, a novel antisense oligonucleotide targeting microRNA-22 (miR-22), ...

In cancer research, one person's junk is increasingly becoming another person's treasure. Scientists have now uncovered new evidence showing how recently evolved "junk DNA" genetic elements can become ...

Biolevate to Advance AI-Native Life Sciences Workflows With NVIDIA BioNeMo Agent Toolkit. Biolevate is integrating NVIDIA BioNeMo Recipes, agentic AI components and GPU-optimized ...

Join us for a fascinating conversation with Dr. Zehra Nizami, Principal Scientist, Head of Business Development & ...

Neurological disorders represent a growing global health challenge, yet the molecular mechanisms underlying their onset and progression remain incompletely ...